P174 Patient-reported outcomes measuring an individuals overall self-rated health after long-term treatment with bulevirtide 2 mg for chronic hepatitis delta in the phase 3 MYR301 trial
Year: 2025
Type: conference-abstract
Authors: Maria Buti, Heiner Wedemeyer, Soo Aleman, Vladimir Chulanov, Viacheslav Morozov, Olga Sagalova, Tatiana Stepanova, Robert Gish, Andrew Lloyd, Dmitry Manuilov, Audrey H Lau, Anu O Osinusi, Marvin Rock, Chong Kim, Arman Sali Sali, Shubhram Pandey, Barinder Singh, Pietro Lampertico
Institutions: Vall d'Hebron Hospital Universitari, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Medizinische Hochschule Hannover, Karolinska University Hospital, Sechenov University, Chelyabinsk State Medical Academy, Hepatitis B Foundation, Gilead Sciences (United States), Pharmacoevidence (India), University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Language: English
Topic: Hepatitis B Virus Studies
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4414963885
Cites:
Cited by:
Related to: